Futura Medical (LON:FUM) Trading 14.7% Higher – What’s Next?

Futura Medical plc (LON:FUM)’s stock price was up 14.7% during trading on Monday . The company traded as high as GBX 1.20 and last traded at GBX 1.17. Approximately 31,081,723 shares changed hands during trading, an increase of 1,673% from the average daily volume of 1,752,719 shares. The stock had previously closed at GBX 1.02.

Futura Medical Price Performance

The company has a market cap of £3.63 million, a P/E ratio of -0.52 and a beta of 1.25. The company’s 50-day moving average is GBX 2.01 and its two-hundred day moving average is GBX 6.67.

Futura Medical (LON:FUM) last issued its earnings results on Tuesday, September 30th. The company reported GBX (2.17) EPS for the quarter. Futura Medical had a negative net margin of 44.64% and a negative return on equity of 56.44%. Equities research analysts anticipate that Futura Medical plc will post 2.8486672 EPS for the current year.

Insider Activity at Futura Medical

In related news, insider Harmesh Suniara sold 4,441,678 shares of the stock in a transaction on Thursday, November 13th. The stock was sold at an average price of GBX 2, for a total transaction of £88,833.56. 25.86% of the stock is owned by company insiders.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women.